✦ LIBER ✦

Dyskinesia of vascular origin. Clinical data and response to therapy in 7 cases

✍ Scribed by M. L. Delodovici; M. V. Calloni; G. Ramponi; D. Porazzi

Publisher: Springer Milan
Year: 1995
Tongue: English
Weight: 386 KB
Volume: 16
Category: Article
ISSN: 1590-1874
DOI: 10.1007/bf02282915

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Re-examination of clinical manifestation

Re-examination of clinical manifestations and response to therapy of fissure-in-ano

✍ Nissim Hananel; Philip H. Gordon 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 496 KB

Morphologic and clinical determinants of

Morphologic and clinical determinants of response to therapy in small cell carcinoma of the lung

✍ James A. Strauchen; Barbara M. Egbert; Jon C. Kosek; Roy Mackintosh; Dayton S. M 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 612 KB

Early prediction of response to therapy:

Early prediction of response to therapy: the clinical implications in Hodgkin’s and non-Hodgkin’s lymphoma

✍ Lale Kostakoglu 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 147 KB

Randomized clinical trial examining the

Randomized clinical trial examining the effect of music therapy in stress response to day surgery

✍ S. Leardi; R. Pietroletti; G. Angeloni; S. Necozione; G. Ranalletta; B. Del Gust 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB

Spinal epidural tumor in patients with p

Spinal epidural tumor in patients with prostate cancer. Clinical and radiographic predictors of response to radiation therapy

✍ Michael J. Zelefsky; Howard I. Scher; George Krol; Russell K. Portenoy; Steven A 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 614 KB

Analysis of clinical and virological fac

Analysis of clinical and virological factors associated with response to alpha interferon therapy in chronic hepatitis C

✍ Dr. J. A. Garson; K. Whitby; R. Deaville; S. Brillanti; M. Foli; C. Masci; M. Mi 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 508 KB

## Abstract Interferon alpha (IFN‐α) therapy is currently the treatment of choice for chronic hepatitis C (HCV) infection, but it fails to achieve a sustained response in approximately 75% of those treated. The factors which determine whether or not an individual will respond to IFN‐α are uncertain